Citadel Advisors
STTK icon

Citadel Advisors’s Shattuck Labs STTK Stock Holding History

Citadel Advisors’s Portfolio STTK Stock Details STTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$209K Buy
+30,100
New +$188K ﹤0.01% 11973
2025
Q4 		– Sell
-22,200
Closed -$53.1K – 14026
2025
Q3 		$53.1K Sell
22,200
-13,800
-38% -$16.9K ﹤0.01% 12167
2025
Q2 		$28.5K Buy
+36,000
New +$34.9K ﹤0.01% 12003
2024
Q4 		– Sell
-300
Closed -$1.05K – 15358
2024
Q3 		$1.05K Sell
300
-2,800
-90% -$10.4K ﹤0.01% 13913
2024
Q2 		$12K Sell
3,100
-12,800
-81% -$104K ﹤0.01% 13005
2024
Q1 		$142K Sell
15,900
-3,900
-20% -$35.7K ﹤0.01% 10840
2023
Q4 		$141K Buy
19,800
+19,100
+2,729% +$52.1K ﹤0.01% 10476
2023
Q3 		$1.06K Buy
+700
New +$1.6K ﹤0.01% 13925
2023
Q2 		– Sell
-4,600
Closed -$13.5K – 15210
2023
Q1 		$13.5K Buy
4,600
+4,400
+2,200% +$15.6K ﹤0.01% 13359
2022
Q4 		$460 Buy
+200
New +$501 ﹤0.01% 14650

Other funds holding STTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $217M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors's STTK Position: Q2 2026 in Review

Citadel Advisors sold out of Shattuck Labs (STTK) in Q2 2026, closing a stake of 148,021 shares — an estimated $923K sold.

Citadel Advisors first reported a position in STTK in Q3 2021 and held it in 14 quarters. The position peaked at $1.52M in Q4 2021. 100 funds tracked by Wall St. Rank hold STTK as of Q2 2026.

  • Citadel Advisors reported no remaining Shattuck Labs position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 148,021 Shattuck Labs shares in Q2 2026, an estimated $923K.
  • Citadel Advisors first reported a position in Shattuck Labs in Q3 2021 and held it in 14 quarters.
  • Citadel Advisors's Shattuck Labs position peaked at $1.52M in Q4 2021.
  • 100 funds tracked by Wall St. Rank held Shattuck Labs as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.